Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1
An efficient synthesis of 29 new binaphthyl-based neutral, and mono- and di-cationic, peptoids is described. Some of these compounds had antibacterial activities with MIC values of 1.9-3.9 μg/mL against Staphylococcus aureus. One peptoid had a MIC value of 6 μg/mL against a methicillin-resistant strain of S. aureus (MRSA) and a MIC value of 2 μg/mL against vancomycin-resistant strains of enterococci (VRE).
Bremner, John B.,Keller, Paul A.,Pyne, Stephen G.,Boyle, Timothy P.,Brkic, Zinka,David, Dorothy M.,Robertson, Mark,Somphol, Kittiya,Baylis, Dean,Coates, Jonathan A.,Deadman, John,Jeevarajah, Darshini,Rhodes, David I.
scheme or table
p. 2611 - 2620
(2010/06/16)
Synthesis of novel N-protected hydrophobic phenylalanines and their application in potential antibacterials
An efficient synthesis of two new N-acetyl-4′-arylphenylalanines is described together with their incorporation into a number of cationic peptoid antibacterial agents, one of which had an MIC of 7.8 μg/mL against Staphylococcus aureus. Crown Copyright
Boyle, Timothy P.,Bremner, John B.,Coates, Jonathan A.,Deadman, John,Keller, Paul A.,Pyne, Stephen G.,Somphol, Kittiya
experimental part
p. 1001 - 1009
(2009/09/06)
PEPTIDIC COMPOUNDS
The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
-
Page/Page column 90; 176
(2008/06/13)
More Articles about upstream products of 900521-64-4
Get Best Price for900521-64-4benzyl (2S,5R,8R)-2-allyl-3,6-diaza-12-(tert-butoxycarboxamido)-8-(9H-9-fluorenylmethyloxycarboxamido)-5-([{2,2,5,7,8-pentamethyl-3,4-dihydro-2H-6-chromenylsulfonamido}guanidino]propyl)-4,7-dioxododecanoate